Using MetMap500, we identified a 13-gene lung cancer metastasis signature linked to metastatic potential, poor prognosis, and broad drug resistance. The signature outperformed prior gene sets and prioritized crizotinib through transcriptomic and network-level associations.
-
Updated
Jul 31, 2026 - R